AstraZeneca PLC (AZN)
206.10
+1.58
(+0.77%)
USD |
NYSE |
Feb 13, 11:36
AstraZeneca Cash from Investing (Quarterly) : -1.501B for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| GSK Plc | -3.184B |
| Mereo BioPharma Group Plc | 0.3027M |
| Biodexa Pharmaceuticals Plc | -- |
| Regeneron Pharmaceuticals, Inc. | 220.30M |
| Bicycle Therapeutics Plc | -0.6709M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 2.405B |
| Cash from Financing (Quarterly) | -3.298B |
| Free Cash Flow | 8.977B |
| Free Cash Flow Per Share (Quarterly) | 0.3585 |
| Free Cash Flow to Equity (Quarterly) | 4.131B |
| Free Cash Flow to Firm (Quarterly) | 1.549B |
| Free Cash Flow Yield | 1.40% |